Today, in the International Women's Day we celebrate the social, economic, cultural, political and mostly scientific achievements of RSG' powerful and successful women! #womensday2023 #womaninRSG #womeninscience #8march

Are you interested in #radioactive compounds and its production? Just joint the curse “Hands-on Training (HoT) on the #Synthesis and #Analytical Control of #Radiopharmaceuticals” that will be held in our campus. All information here: eshop.cinch-project.eu/products/Hands…

This week, the RSG participated at the 2nd International Workshop on Radiobiology of Molecular Radionuclide Therapy (#IWRMR), London, with one oral communication and two posters. We congratulate our PhD student Catarina Pinto for her Best Poster Prize sponsored by @sckcen!

Exquisite example of the contribution of Radiopharmaceutical Sciences to the development of Antibody–drug conjugates (ADCs) with high clinical translational potential! 👇Check the recent work of RSG and his collaboratores on Scientific Reports nature.com/articles/s4159…

Theranostics is the future!

The Radiopharmaceutical Sciences Group - C2TN is waiting for you in the Instituto Superior Técnico #openday! Come and visit us to learn a bit more about what we do 😉

From 11th to 14th September 2023, the Radiopharmaceutical Sciences Group - C2TN in organizing, under the scope of @MedRadionuclide the "PRISMAP Summer School on radiopharmaceutical science: from radiochemistry to preclinical studies". prismap.eu/news/events-fe…

We are happy to announce that EPI 2023 - 18th Iberian Peptide Meeting will take place from the 27th to the 29th of November, 2023. Deadline for the early-bird registration and abstract submission: July 31st, 2023. 👇👇👇 iberian-peptide-meeting.github.io/XVIII/ Radiopharmaceutical Sciences Group - C2TN iMM ITQB NOVA

🌤 ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ ☁ Radioactivity was discovered by accident, thanks to a cloudy day. This 60 seconds video explains how.

NEWS!!!! Challenges and advantages of Auger Electron Radiopharmaceutical Therapy (AE-RPT) best suited for the treatment of oncologic small disease, with the advantage of lower risks of normal-tissue toxicity. Just published on JNM, a top jo to all co-auth jnm.snmjournals.org/content/64/9/1…

🔔 Ongoing event!! 🔔 prismap.eu/news/events-fe… @MedRadionuclide

PRISMAP school @MedRadionuclide visit to ChampalimaudF

👉PRISMAP Public Event👈 “CHALLENGES IN NUCLEAR MEDICINE” 📅28 November 2023 🏥Lisbon School of Medicine, Aula Magna Portuguese and Spanish researchers will present their recent findings and invite to discuss challenges in nuclear medicine. More info: prismap.eu/news/events-fe…

Do not forget to register! tecnico.ulisboa.pt/pt/eventos/wor…

Congrats to Diogo Engrácia and his supervisor Dr Filipa Mendes for the successfully achieved Master Degree in Bioengineering, Regenerative and Precision Medicine dbe.ist @tecnico_lisboa

Congrats to Diogo Engrácia and his supervisor Dr Filipa Mendes for the successfully achieved Master Degree in Bioengineering, Regenerative and Precision Medicine Dep_Bioengineering@Tecnico Instituto Superior Técnico

Welcome to Lisbon @MedRadionuclide Instituto Superior Técnico C2TN

Directly from EPI2023 in Sesimbra!! A joint effort Instituto Superior Técnico / ITQB NOVA / iMM Today was the time to listen the interesting talks of Rita Paiva de Melo and Cátia Rosa, from Radiopharmaceutical Sciences Group - C2TN. See you tomorrow!